POU5F1 and colorectal carcinoma: However, we concluded that Oct4-high tumors might metastasize in a clinical context, so an additional therapeutic intervention for Oct4-high tumors and/or treatment to target Oct4 may reduce liver metastasis in CRC patients and improve their prognosis.